US Stock MarketDetailed Quotes

Harmony Biosciences (HRMY)

Watchlist
  • 30.090
  • -0.670-2.18%
Close May 15 16:00 ET
  • 30.090
  • 0.0000.00%
Post 20:01 ET
1.74BMarket Cap12.13P/E (TTM)

Harmony Biosciences (HRMY) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
16.59%215.39M
21.51%868.45M
21.12%243.78M
28.71%239.46M
16.01%200.49M
19.48%184.73M
22.80%714.73M
19.51%201.27M
16.08%186.04M
28.76%172.81M
Operating revenue
16.59%215.39M
21.51%868.45M
21.12%243.78M
28.71%239.46M
16.01%200.49M
19.48%184.73M
22.80%714.73M
19.51%201.27M
16.08%186.04M
28.76%172.81M
Cost of revenue
39.13%44.51M
26.48%198.34M
25.98%68.55M
39.44%59.65M
18.69%38.15M
16.41%31.99M
29.35%156.82M
26.09%54.41M
32.46%42.78M
28.53%32.14M
Gross profit
11.87%170.88M
20.11%670.11M
19.32%175.23M
25.51%179.81M
15.40%162.34M
20.14%152.74M
21.08%557.92M
17.24%146.86M
11.95%143.26M
28.81%140.67M
Operating expense
38.44%133.58M
25.76%461.64M
49.98%136.67M
40.18%114.32M
-4.32%114.16M
28.49%96.49M
36.59%367.09M
7.13%91.13M
28.50%81.55M
91.50%119.31M
Selling and administrative expenses
3.63%64.2M
22.95%272.05M
53.62%86.74M
5.69%59.36M
14.83%64M
17.10%61.95M
14.83%221.27M
3.12%56.47M
22.19%56.16M
17.73%55.73M
-Selling and marketing expense
3.20%31.69M
7.75%119.51M
5.72%29.18M
7.15%29.55M
5.49%30.07M
12.77%30.71M
13.87%110.92M
2.66%27.6M
17.76%27.58M
16.22%28.51M
-General and administrative expense
4.05%32.51M
38.23%152.54M
99.42%57.56M
4.27%29.81M
24.61%33.92M
21.68%31.24M
15.81%110.35M
3.56%28.87M
26.79%28.59M
19.36%27.22M
Research and development costs
100.88%69.38M
30.01%189.59M
44.04%49.93M
116.50%54.96M
-21.11%50.16M
55.66%34.54M
91.72%145.83M
14.39%34.67M
45.08%25.39M
324.76%63.58M
Operating profit
-33.70%37.29M
9.25%208.47M
-30.81%38.56M
6.12%65.49M
125.60%48.18M
8.09%56.25M
-0.63%190.83M
38.64%55.73M
-4.34%61.71M
-54.47%21.36M
Net non-operating interest income expense
108.86%2.52M
595.51%7.28M
761.19%2.31M
261.13%2.11M
448.17%1.65M
1,228.97%1.21M
111.59%1.05M
138.29%268K
120.10%584K
110.84%301K
Non-operating interest income
14.14%5.76M
18.24%21.92M
30.76%5.85M
16.18%5.73M
12.56%5.3M
13.91%5.04M
25.88%18.54M
9.30%4.48M
20.12%4.93M
36.69%4.71M
Non-operating interest expense
-15.69%3.23M
-16.27%14.65M
-15.75%3.55M
-16.72%3.62M
-17.21%3.65M
-15.41%3.84M
-26.35%17.5M
-12.24%4.21M
-37.99%4.35M
-29.17%4.4M
Other net income (expense)
53.99%-127K
-900.00%-680K
-165.63%-105K
14.52%-106K
-621.62%-193K
-95.74%-276K
99.29%-68K
-17.10%160K
98.73%-124K
219.35%37K
Special income (charges)
----
--0
----
----
----
----
--0
--0
--0
----
Other non- operating income (expenses)
53.99%-127K
-900.00%-680K
-165.63%-105K
14.52%-106K
-621.62%-193K
-95.74%-276K
-142.77%-68K
-17.10%160K
-2,380.00%-124K
219.35%37K
Income before tax
-30.59%39.69M
12.13%215.06M
-27.42%40.76M
8.56%67.49M
128.81%49.64M
10.41%57.18M
10.62%191.8M
41.49%56.16M
19.95%62.17M
-50.80%21.69M
Income tax
-38.03%7.2M
21.74%56.38M
173.56%18.27M
3.41%16.63M
-2.40%9.86M
-13.63%11.62M
3.97%46.31M
-48.94%6.68M
20.24%16.08M
3.14%10.1M
Net income
-28.69%32.49M
9.07%158.69M
-54.55%22.49M
10.35%50.87M
243.16%39.78M
18.85%45.56M
12.91%145.49M
85.95%49.48M
19.84%46.09M
-66.21%11.59M
Net income continuous Operations
-28.69%32.49M
9.07%158.69M
-54.55%22.49M
10.35%50.87M
243.16%39.78M
18.85%45.56M
12.91%145.49M
85.95%49.48M
19.84%46.09M
-66.21%11.59M
Minority interest income
Net income attributable to the parent company
-28.69%32.49M
9.07%158.69M
-54.55%22.49M
10.35%50.87M
243.16%39.78M
18.85%45.56M
12.91%145.49M
85.95%49.48M
19.84%46.09M
-66.21%11.59M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-28.69%32.49M
9.07%158.69M
-54.55%22.49M
10.35%50.87M
243.16%39.78M
18.85%45.56M
12.91%145.49M
85.95%49.48M
19.84%46.09M
-66.21%11.59M
Basic earnings per share
-29.11%0.56
7.81%2.76
-55.17%0.39
8.64%0.88
245.00%0.69
16.18%0.79
17.97%2.56
89.13%0.87
26.56%0.81
-64.91%0.2
Diluted earnings per share
-29.49%0.55
7.97%2.71
-55.29%0.38
10.13%0.87
240.00%0.68
16.42%0.78
17.84%2.51
88.89%0.85
25.40%0.79
-64.29%0.2
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 16.59%215.39M21.51%868.45M21.12%243.78M28.71%239.46M16.01%200.49M19.48%184.73M22.80%714.73M19.51%201.27M16.08%186.04M28.76%172.81M
Operating revenue 16.59%215.39M21.51%868.45M21.12%243.78M28.71%239.46M16.01%200.49M19.48%184.73M22.80%714.73M19.51%201.27M16.08%186.04M28.76%172.81M
Cost of revenue 39.13%44.51M26.48%198.34M25.98%68.55M39.44%59.65M18.69%38.15M16.41%31.99M29.35%156.82M26.09%54.41M32.46%42.78M28.53%32.14M
Gross profit 11.87%170.88M20.11%670.11M19.32%175.23M25.51%179.81M15.40%162.34M20.14%152.74M21.08%557.92M17.24%146.86M11.95%143.26M28.81%140.67M
Operating expense 38.44%133.58M25.76%461.64M49.98%136.67M40.18%114.32M-4.32%114.16M28.49%96.49M36.59%367.09M7.13%91.13M28.50%81.55M91.50%119.31M
Selling and administrative expenses 3.63%64.2M22.95%272.05M53.62%86.74M5.69%59.36M14.83%64M17.10%61.95M14.83%221.27M3.12%56.47M22.19%56.16M17.73%55.73M
-Selling and marketing expense 3.20%31.69M7.75%119.51M5.72%29.18M7.15%29.55M5.49%30.07M12.77%30.71M13.87%110.92M2.66%27.6M17.76%27.58M16.22%28.51M
-General and administrative expense 4.05%32.51M38.23%152.54M99.42%57.56M4.27%29.81M24.61%33.92M21.68%31.24M15.81%110.35M3.56%28.87M26.79%28.59M19.36%27.22M
Research and development costs 100.88%69.38M30.01%189.59M44.04%49.93M116.50%54.96M-21.11%50.16M55.66%34.54M91.72%145.83M14.39%34.67M45.08%25.39M324.76%63.58M
Operating profit -33.70%37.29M9.25%208.47M-30.81%38.56M6.12%65.49M125.60%48.18M8.09%56.25M-0.63%190.83M38.64%55.73M-4.34%61.71M-54.47%21.36M
Net non-operating interest income expense 108.86%2.52M595.51%7.28M761.19%2.31M261.13%2.11M448.17%1.65M1,228.97%1.21M111.59%1.05M138.29%268K120.10%584K110.84%301K
Non-operating interest income 14.14%5.76M18.24%21.92M30.76%5.85M16.18%5.73M12.56%5.3M13.91%5.04M25.88%18.54M9.30%4.48M20.12%4.93M36.69%4.71M
Non-operating interest expense -15.69%3.23M-16.27%14.65M-15.75%3.55M-16.72%3.62M-17.21%3.65M-15.41%3.84M-26.35%17.5M-12.24%4.21M-37.99%4.35M-29.17%4.4M
Other net income (expense) 53.99%-127K-900.00%-680K-165.63%-105K14.52%-106K-621.62%-193K-95.74%-276K99.29%-68K-17.10%160K98.73%-124K219.35%37K
Special income (charges) ------0------------------0--0--0----
Other non- operating income (expenses) 53.99%-127K-900.00%-680K-165.63%-105K14.52%-106K-621.62%-193K-95.74%-276K-142.77%-68K-17.10%160K-2,380.00%-124K219.35%37K
Income before tax -30.59%39.69M12.13%215.06M-27.42%40.76M8.56%67.49M128.81%49.64M10.41%57.18M10.62%191.8M41.49%56.16M19.95%62.17M-50.80%21.69M
Income tax -38.03%7.2M21.74%56.38M173.56%18.27M3.41%16.63M-2.40%9.86M-13.63%11.62M3.97%46.31M-48.94%6.68M20.24%16.08M3.14%10.1M
Net income -28.69%32.49M9.07%158.69M-54.55%22.49M10.35%50.87M243.16%39.78M18.85%45.56M12.91%145.49M85.95%49.48M19.84%46.09M-66.21%11.59M
Net income continuous Operations -28.69%32.49M9.07%158.69M-54.55%22.49M10.35%50.87M243.16%39.78M18.85%45.56M12.91%145.49M85.95%49.48M19.84%46.09M-66.21%11.59M
Minority interest income
Net income attributable to the parent company -28.69%32.49M9.07%158.69M-54.55%22.49M10.35%50.87M243.16%39.78M18.85%45.56M12.91%145.49M85.95%49.48M19.84%46.09M-66.21%11.59M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -28.69%32.49M9.07%158.69M-54.55%22.49M10.35%50.87M243.16%39.78M18.85%45.56M12.91%145.49M85.95%49.48M19.84%46.09M-66.21%11.59M
Basic earnings per share -29.11%0.567.81%2.76-55.17%0.398.64%0.88245.00%0.6916.18%0.7917.97%2.5689.13%0.8726.56%0.81-64.91%0.2
Diluted earnings per share -29.49%0.557.97%2.71-55.29%0.3810.13%0.87240.00%0.6816.42%0.7817.84%2.5188.89%0.8525.40%0.79-64.29%0.2
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More